InsiderClue
← All stocks

Theravance Biopharma, Inc.

TBPH Net buying
CIK 0001583107 #2645 in the set updated 17 Sep 2026
Bought (120 mo)
$22.27M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$17.31M
$1.86M on a plan · $1.66M straight out of an exercise
Sold at will
$13.79M
44 of 72 sales
Net
+$4.96M
+$8.48M against sales at will

By person

34 insiders · 82 transactions
28.0×

Rick E Winningham holds 28.0 times base salary in stock. $29.36M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.00, the price COM was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Samaha Eli
10% owner
$20.92M (3)
$5.79M (3)
+$15.12M
9,174,453
$155.98M
+30.8%
Shafer Bradford J
EVP, Gen. Counsel, Secretary
—
$2.71M (8)
−$2.71M
277,831
$4.72M
+37.5%
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
—
$1.89M (24) scheduled
−$1.89M
226,790
$3.86M
−29.1%
BROSHY ERAN
Director
—
$1.66M (5) scheduled
−$1.66M
44,703
$760.00K
−17.2%
GALA RENEE D
SVP, Chief Financial Officer
—
$1.41M (4)
−$1.41M
157,657
$2.68M
−32.8%
HAUMANN BRETT K
Chief Medical Officer
—
$898.21K (3)
−$898.21K
242,499
$4.12M
+28.8%
MALKIEL BURTON G
Director
$760.21K (3)
—
+$760.21K
115,589
$1.97M
+335.0%
WORBOYS PHILIP D
SVP, RESEARCH & TRANSL SCIENCE
—
$743.06K (4)
−$743.06K
330,752
$5.62M
+82.3%
Hindman Andrew A.
SVP, CHIEF FINANCIAL OFFICER
—
$716.24K (1)
−$716.24K
384,714
$6.54M
+5,951%
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
—
$592.92K (14)
−$592.92K
314,915
$5.35M
+182.8%
Winningham Rick E
CHIEF EXECUTIVE OFFICER
$245.00K (1)
$559.50K (1)
−$314.50K
1,726,989
$29.36M
+93.3%
HEGDE SHARATHCHANDRA S
SVP, Research
—
$223.17K (2)
−$223.17K
259,900
$4.42M
+49.8%
Fore Henrietta
Director
$143.93K (1)
—
+$143.93K
24,000
$408.03K
+100.0%
PASQUALONE FRANK
SVP, CHIEF BUSINESS OFFICER
$105.36K (1)
—
+$105.36K
429,783
$7.31M
+90.8%
WHITESIDES GEORGE M
Director
$98.76K (1)
—
+$98.76K
249,076
$4.23M
+9.7%
O'Connor Donal
Director
—
$81.83K (2)
−$81.83K
80,213
$1.36M
+791.3%
SABESAN VIJAY
SVP, TECHNICAL OPERATIONS
—
$21.60K (1)
−$21.60K
235,524
$4.00M
+49.0%
PITZER KENNETH R
SVP, PROD STRAT & COMM PLNG
—
—
—
380,123
$6.46M
+130.2%
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
—
—
—
355,168
$6.04M
+47.0%
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
—
—
—
336,841
$5.73M
+64.7%
LEE JUNNING
Sr. VP, Technical Operations
—
—
—
234,071
$3.98M
−5.4%
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
—
—
—
189,826
$3.23M
+30.6%
BRADY ANN
PRESIDENT, TBIL
—
—
—
110,319
$1.88M
+42.6%
MITCHELL DEAN J
Director
—
—
—
97,213
$1.65M
+710.1%
SULIMAN SHEHNAAZ
SVP, Corp Dev & Strategy
—
—
—
97,198
$1.65M
+5,515%
Smaldone Alsup Laurie
Director
—
—
—
80,989
$1.38M
—
Gunderson Robert V JR
Director
—
—
—
78,940
$1.34M
+97.8%
YOUNG WILLIAM D
Director
—
—
—
78,010
$1.33M
+167.9%
PAKIANATHAN DEEPIKA
Director
—
—
—
64,074
$1.09M
—
Molineaux Susan
Director
—
—
—
51,034
$867.64K
+325.3%
GRAY SUSANNAH
Director
—
—
—
48,146
$818.54K
—
RINGROSE PETER S
Director
—
—
—
37,999
$646.03K
+146.3%
Grant Jeremy T
Director
—
—
—
32,954
$560.26K
—
GSK plc entity
Former 10% Owner
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

82
Insider
Date
Role
Action
Shares
Price
Amount
Samaha Eli
1 Jul 2026
10% owner
Sell indirect
37,799
$17.00
$642.63K
Samaha Eli
30 Jun 2026
10% owner
Sell indirect
25,027
$17.13
$428.79K
Samaha Eli
29 Jun 2026
10% owner
Sell indirect
273,871
$17.23
$4.72M
Farnum Rhonda
15 Jun 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
6,657
$16.39
$109.08K
Farnum Rhonda
15 Jun 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
3,328
$16.38
$54.53K
Farnum Rhonda
15 Jun 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
3,329
$16.39
$54.56K
Farnum Rhonda
16 Mar 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
7,766
$13.92
$108.07K
Farnum Rhonda
16 Mar 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
15,534
$14.00
$217.48K
Farnum Rhonda
16 Mar 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
7,767
$13.92
$108.09K
Farnum Rhonda
3 Dec 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
15,534
$18.75
$291.25K
Farnum Rhonda
3 Dec 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
7,766
$18.75
$145.62K
Farnum Rhonda
3 Dec 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
7,767
$18.75
$145.63K
BROSHY ERAN
26 Nov 2025
Director
Sold after exercise
15,501
$20.00
$310.02K
BROSHY ERAN
26 Nov 2025
Director
Sold after exercise
14,000
$20.00
$280.00K
BROSHY ERAN
11 Nov 2025
Director
Sold after exercise
14,000
$18.50
$259.00K
BROSHY ERAN
11 Nov 2025
Director
Sold after exercise
15,500
$17.00
$263.50K
BROSHY ERAN
11 Nov 2025
Director
Sold after exercise
29,500
$18.50
$545.75K
Farnum Rhonda
14 Jul 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$11.39
$45.55K
Farnum Rhonda
14 Jul 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
5,318
$11.39
$60.55K
Farnum Rhonda
14 Jul 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
682
$11.39
$7.77K
Farnum Rhonda
2 Jun 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
24,000
$11.00
$264.00K
Farnum Rhonda
21 Apr 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$9.00
$36.00K
Farnum Rhonda
21 Jan 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$9.00
$36.00K
Farnum Rhonda
11 Nov 2024
SVP, COMM & MEDICAL AFFAIRS
Sell
4,000
$9.00
$36.00K
Samaha Eli
7 Aug 2024
10% owner
Buy indirect
999,800
$7.80
$7.80M
Farnum Rhonda
10 Jul 2024
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$9.00
$36.00K
Samaha Eli
1 May 2024
10% owner
Buy indirect
499,324
$8.75
$4.37M
Samaha Eli
1 May 2024
10% owner
Buy indirect
999,800
$8.75
$8.75M
Farnum Rhonda
22 Feb 2024
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,254
$8.71
$10.92K
Farnum Rhonda
21 Nov 2023
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,378
$10.29
$14.18K
GRAHAM RICHARD A
14 Nov 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$10.22
$25.37K
GRAHAM RICHARD A
16 Oct 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$9.03
$22.41K
GRAHAM RICHARD A
14 Sep 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$9.89
$24.55K
Farnum Rhonda
22 Aug 2023
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,807
$9.47
$17.11K
GRAHAM RICHARD A
11 Aug 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,322
$9.99
$23.20K
GRAHAM RICHARD A
14 Jul 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,322
$9.84
$22.85K
GRAHAM RICHARD A
14 Jun 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,322
$10.69
$24.82K
Farnum Rhonda
8 Jun 2023
SVP, COMM & MEDICAL AFFAIRS
Sell
1,790
$11.13
$19.92K
GRAHAM RICHARD A
15 May 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,322
$11.26
$26.15K
GRAHAM RICHARD A
14 Apr 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,323
$11.88
$27.60K
GRAHAM RICHARD A
14 Mar 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,323
$10.32
$23.97K
Farnum Rhonda
9 Mar 2023
SVP, COMM & MEDICAL AFFAIRS
Sell
4,000
$10.20
$40.80K
GRAHAM RICHARD A
6 Mar 2023
SVP, RESEARCH & DEVELOPMENT
Sell
2,323
$10.05
$23.35K
Winningham Rick E
14 Dec 2022
CHIEF EXECUTIVE OFFICER
Sell
50,000
$11.19
$559.50K
GRAHAM RICHARD A
1 Dec 2022
SVP, RESEARCH & DEVELOPMENT
Sell
2,084
$10.73
$22.36K
Hindman Andrew A.
18 Nov 2022
SVP, CHIEF FINANCIAL OFFICER
Sell
65,000
$11.02
$716.24K
GRAHAM RICHARD A
16 Aug 2022
SVP, DEVELOPMENT
Sell
4,906
$9.71
$47.64K
GRAHAM RICHARD A
9 Aug 2022
SVP, DEVELOPMENT
Sell
15,086
$8.79
$132.61K
Farnum Rhonda
23 May 2022
SVP, COMM & MEDICAL AFFAIRS
Sell
1,081
$8.93
$9.65K
Farnum Rhonda
28 Feb 2022
SVP, COMM & MEDICAL AFFAIRS
Sell
2,356
$10.16
$23.95K
WORBOYS PHILIP D
9 Mar 2021
SVP, Research & Transl Science
Sell
8,829
$20.00
$176.58K
GRAHAM RICHARD A
14 Dec 2020
SVP, Development
Sell
7,500
$19.47
$146.06K
WORBOYS PHILIP D
3 Dec 2020
SVP, Research & Transl Science
Sell
4,246
$18.00
$76.43K
HAUMANN BRETT K
21 Aug 2020
Chief Medical Officer
Sell
25,000
$18.29
$457.24K
WORBOYS PHILIP D
20 Aug 2020
SVP, Research & Transl Science
Sell
17,103
$18.00
$307.85K
SABESAN VIJAY
12 Dec 2019
SVP, Technical Operations
Sell
1,027
$21.03
$21.60K
O'Connor Donal
17 May 2019
Director
Sell
2,673
$20.19
$53.97K
O'Connor Donal
16 May 2019
Director
Sell
1,327
$21.00
$27.87K
HEGDE SHARATHCHANDRA S
5 Mar 2019
SVP, Research
Sell
5,690
$24.50
$139.41K
HEGDE SHARATHCHANDRA S
4 Mar 2019
SVP, Research
Sell
3,343
$25.06
$83.76K
WORBOYS PHILIP D
12 Sep 2018
SVP, Translational Science
Sell
6,393
$28.50
$182.20K
Shafer Bradford J
27 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
7,119
$27.71
$197.28K
GALA RENEE D
15 Aug 2018
SVP, Chief Financial Officer
Sell
1,700
$27.43
$46.62K
GALA RENEE D
15 Aug 2018
SVP, Chief Financial Officer
Sell
39,839
$26.71
$1.06M
GALA RENEE D
14 Aug 2018
SVP, Chief Financial Officer
Sell
2,204
$27.74
$61.14K
Shafer Bradford J
8 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
25,355
$27.85
$706.18K
Shafer Bradford J
7 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
4,127
$28.03
$115.69K
Shafer Bradford J
7 Aug 2018
EVP, Gen. Counsel, Secretary
Sell
1,818
$28.99
$52.71K
Shafer Bradford J
8 Jun 2018
EVP, Gen. Counsel, Secretary
Sell
3,900
$23.66
$92.26K
Shafer Bradford J
6 Jun 2018
EVP, Gen. Counsel, Secretary
Sell
10,140
$24.09
$244.27K
MALKIEL BURTON G
21 May 2018
Director
Buy
1,000
$22.54
$22.54K
GALA RENEE D
18 May 2018
SVP, Chief Financial Officer
Sell
10,000
$24.29
$242.88K
Shafer Bradford J
6 Sep 2017
EVP, Gen. Counsel, Secretary
Sell
14,670
$30.77
$451.35K
PASQUALONE FRANK
21 Aug 2017
SVP, Chief Comm Ops Officer
Buy
4,000
$26.34
$105.36K
Winningham Rick E
11 Aug 2017
Chief Executive Officer
Buy
10,000
$24.50
$245.00K
Fore Henrietta
11 Aug 2017
Director
Buy
6,000
$23.99
$143.93K
MALKIEL BURTON G
11 Aug 2017
Director
Buy indirect
15,000
$24.59
$368.82K
MALKIEL BURTON G
11 Aug 2017
Director
Buy
15,000
$24.59
$368.85K
WHITESIDES GEORGE M
11 Aug 2017
Director
Buy indirect
4,000
$24.69
$98.76K
HAUMANN BRETT K
7 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sell
424
$30.80
$13.06K
HAUMANN BRETT K
6 Mar 2017
SVP Clin Dev & Chief Med Ofc
Sell
13,576
$31.52
$427.92K
Shafer Bradford J
3 Mar 2017
EVP, Gen. Counsel, Secretary
Sell
26,829
$31.86
$854.77K

What was left out

Form 4 filings counted 503
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 0
Sales on a Rule 10b5-1 plan 23
Sales straight out of an exercise 5
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 19,572,994
Sales filed before the plan box existed 35
History held since 22 Nov 2016